Malaysia’s medical device regulatory framework, governed by the Medical Device Authority (MDA), continues to evolve with increasing emphasis on pre- and post-market compliance. Whether you are registering a low-risk (Class A) product or a moderate-to-high-risk (Class B, C, or D) device, understanding the documentation requirements is essential for a smooth and timely approval process.
This article outlines the latest document requirements for medical device registration in Malaysia as of 2025, focusing on Class A, B, C, and D devices. It also highlights the role of the local agent or Authorized Representative (AR) and provides practical tips for submission readiness.
Class A Device Registration: No CAB Involvement
For Class A devices, which are deemed low-risk, a Conformity Assessment Body (CAB) evaluation is not required. Applicants submit the following documents directly to the MDA:
- Manufacturer’s ISO Certificate
Proof of a certified Quality Management System, typically ISO 13485. - Pre-Market Approval (if applicable)
Valid certification or clearance from established regulatory authorities such as FDA (U.S.), EC (EU), TGA (Australia), Canada TPD, or Japan MHLW. This is not mandatory, but it strengthens the application. - Post-Market Vigilance History (last 3 years)
A report detailing any adverse events, recalls, or field safety corrective actions related to the product. - Product Catalogue
Marketing materials describing the product, specifications, intended use, and available variants. - Declaration of Conformity (DoC) – MDA Format
A formal declaration that the product complies with the Malaysian Medical Device Regulation 2012. The format is provided in Appendix 1A (page 214). - Declaration of Conformity (EU Format) (if applicable)
An optional document that mirrors the EU format for international harmonization. - Product-Specific Reports (if applicable)
Includes:- Sterilization validation report
- Calibration certificate
- IEC 60601 test report (for electrical safety)
- Biocompatibility test report
- Product List (MDA Format)
A complete list of product models or configurations to be registered. - GMDN Code
The Global Medical Device Nomenclature (GMDN) code that uniquely identifies the product category. - Product Label, IFU, and Labelling Declaration
- Labels and Instructions for Use (IFU) as used in other approved markets.
- Declaration that the Malaysian version is identical.
- For home-use devices, Bahasa Malaysia translation is mandatory.
- The label must include the MDA product certificate number.
- The label must include information about the Malaysian Authorized Representative (AR).
- Letter of Authorization (LOA) to Sign DoC
Required if the signatory is not part of the top management. - LOA to Appoint the local agent as Authorized Representative (AR)
A formal letter designating the Establishment Applicant (often a local distributor or consultant) as the AR in Malaysia.
These documents, once submitted and approved, allow for the issuance of the product registration certificate by the MDA. Since there is no CAB involvement for Class A devices, proper formatting and completeness of documentation are especially important.
Class B, C, and D Device Registration: CAB + MDA Review
For Class B, Class C, and Class D medical devices in Malaysia, a Conformity Assessment Body (CAB) must first evaluate the technical documentation. Once the CAB issues a favorable assessment, the documents are then submitted to the Medical Device Authority (MDA) for final approval. The documentation required includes a comprehensive set of administrative, technical, and regulatory materials:
- Manufacturer’s ISO 13485 Certificate
Proof of an active and valid Quality Management System certification. - Pre-Market Clearance/Approval by Other Authorities (if applicable)
Certificates or approvals from international regulators such as FDA, EC, TGA, Canada TPD, or Japan MHLW. - CSDT (Common Submission Dossier Template)
Must follow the MDA template and guidance document. - Essential Requirements for Safety and Performance (ERSP) Checklist
- List of Reported Ongoing Incidents Globally
- List of Resolved Incidents in the Past 5 Years
- Product Catalogue
- Declaration of Conformity (MDA Format)
Must adhere to the format outlined in Appendix 1A of the Medical Device Regulation 2012. - Declaration of Conformity (EU Format) (if applicable)
- Sterilization Validation Report / Calibration Certificate / IEC 60601 Test Certificate / Biocompatibility Report (if applicable)
- Product Description
- Product Intended Use
- Product Classification and Rule
According to the MDA Classification (refer to Medical Device Regulation 2012, page 148). - Product Grouping Information
(Refer to Medical Device Regulation 2012, page 170). - Product List (in MDA format)
- Product Label and IFU
- Declaration that the Malaysian labeling is identical to the labeling used in other approved markets.
- Bahasa Malaysia translation is mandatory for home-use devices.
- Include Malaysia AR details
- The label must clearly identify the location of the MDA product certificate number.
- Production Flow Chart
- Regulatory Agreement (if applicable)
- GMDN Code of the Product
- Letter of Authorization (LOA) to Sign DoC
Required if the designated signatory is not part of the top management. - LOA to Appoint the EAP as Authorized Representative (AR)
- CAB Conformity Assessment Report Form
Must be submitted in the format provided by the CAB.
As the process involves two layers of scrutiny, careful preparation and consistency across all materials are essential.
Role of the Malaysian Authorized Representative (AR)
Every foreign manufacturer, without an office in Malaysia, must appoint a Malaysia-based AR. The AR is responsible for:
- Submitting the registration application
- Holding the Declaration of Conformity
- Acting as the point of contact for MDA inspections or inquiries
- Ensuring labelling includes their contact details
- Coordinating post-market surveillance and adverse event reporting
The AR’s information must appear on the product label, including the MDA registration number once granted.
Electronic Submission and Review Timelines
Unlike in countries such as Japan and Taiwan, both the Conformity Assessment Body (CAB) and the Medical Device Authority (MDA) in Malaysia accept electronic signatures. This allows for a fully digital submission process as no hard copies or physical shipment of documents are required.
Review Timelines:
- Class B, C, and D Devices:
- CAB Review: Approximately 2-4 months upon submission of all relevant documents
- MDA Review: Typically 3-7 months, but based on our consultants’ recent experience, MDA review can be shorter as the CAB assessment is highly comprehensive and acts as the primary review step.
- Class A Devices:
- MDA Review Only: Typically 3-6 months upon full document submission
Given the thorough nature of the CAB evaluation, products are essentially “pre-cleared” by the time the file reaches the MDA, which helps reduce the overall registration timeline.
Conclusion
Malaysia’s medical device registration process continues to emphasize transparency, international harmonization, and post-market oversight. Whether submitting a simple Class A application or preparing a technical file for a Class D device, organizing the right documents in the correct format is key to avoiding delays.
Working closely with a knowledgeable AR and aligning documentation with MDA expectations ensures that your product enters the Malaysian market smoothly and compliantly. Please feel free to contact us if you need help with medical device registration in Malaysia.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.